Coya Therapeutics Reports Additional Biomarker And Imaging Data Showing Decrease In Neuroinflammation With COYA 301
Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic programs intended to enhance Treg function, including ...